Altered serum levels of cytokines in patients with myasthenia gravis

Background: Myasthenia gravis (MG) is an autoimmune disease characterized by generalized skeletal muscle contraction weakness due to autoantibodies targeting neural-muscular junctions. Here, we investigated the relationship between key cytokines and MG type, disease course, antibodies, and comorbidi...

Full description

Bibliographic Details
Main Authors: Shu-Li Wei, Chun-Lin Yang, Wei-Yue Si, Jing Dong, Xue-Lu Zhao, Peng Zhang, Heng Li, Cong-Cong Wang, Min Zhang, Xiao-Li Li, Rui-Sheng Duan
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023109534
_version_ 1797336942595014656
author Shu-Li Wei
Chun-Lin Yang
Wei-Yue Si
Jing Dong
Xue-Lu Zhao
Peng Zhang
Heng Li
Cong-Cong Wang
Min Zhang
Xiao-Li Li
Rui-Sheng Duan
author_facet Shu-Li Wei
Chun-Lin Yang
Wei-Yue Si
Jing Dong
Xue-Lu Zhao
Peng Zhang
Heng Li
Cong-Cong Wang
Min Zhang
Xiao-Li Li
Rui-Sheng Duan
author_sort Shu-Li Wei
collection DOAJ
description Background: Myasthenia gravis (MG) is an autoimmune disease characterized by generalized skeletal muscle contraction weakness due to autoantibodies targeting neural-muscular junctions. Here, we investigated the relationship between key cytokines and MG type, disease course, antibodies, and comorbidities. Method: Cytokine levels in serum samples collected from MG (n = 45) and healthy control (HC, n = 38) patients from January 2020 to June 2022 were quantified via flow cytometry. Results: Levels of IL-6 were higher in the MG group versus healthy individuals (p = 0.026) and in patients with generalized versus ocular MG (p = 0.019). IL-6 levels were positively correlated with QMG score. In patients with MG with both AChR and Titin antibodies, serum levels of sFas and granulysin were higher than in those with AChR alone (p = 0.036, and p = 0.028, respectively). LOMG had a reduction in serum levels of IL-2 compared to EOMG (p = 0.036). LOMG patients with diabetes had lower serum levels of IL-2, IL-4, and IFN-γ (p = 0.044, p = 0.038, and p = 0.047, respectively) versus those without diabetes. sFas in the MG with Abnormal thymus were reduced compared to those in MG with Normal thymus (p = 0.008). Conclusions: This study revealed a positive correlation between IL-6 level and MG status. Serum cytokine levels of the AChR + Titin MG group differed from those of the AChR group. LOMG had a lower IL-2 level. Comorbidities affect some cytokines in peripheral blood in MG serum.
first_indexed 2024-03-08T09:02:10Z
format Article
id doaj.art-0fb749b8ac854f32a0f19e9513af1b18
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-08T09:02:10Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-0fb749b8ac854f32a0f19e9513af1b182024-02-01T06:33:18ZengElsevierHeliyon2405-84402024-01-01101e23745Altered serum levels of cytokines in patients with myasthenia gravisShu-Li Wei0Chun-Lin Yang1Wei-Yue Si2Jing Dong3Xue-Lu Zhao4Peng Zhang5Heng Li6Cong-Cong Wang7Min Zhang8Xiao-Li Li9Rui-Sheng Duan10Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China; Shandong Institute of Neuroimmunology, Jinan 250014, PR China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, Jinan 250014, PR ChinaDepartment of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China; Shandong Institute of Neuroimmunology, Jinan 250014, PR China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China; Shandong Institute of Neuroimmunology, Jinan 250014, PR China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China; Shandong Institute of Neuroimmunology, Jinan 250014, PR China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China; Shandong Institute of Neuroimmunology, Jinan 250014, PR China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, Jinan 250014, PR ChinaDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China; Shandong Institute of Neuroimmunology, Jinan 250014, PR China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, Jinan 250014, PR China; Corresponding author. Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China.Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, PR China; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan 250014, PR China; Shandong Institute of Neuroimmunology, Jinan 250014, PR China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, Jinan 250014, PR China; Corresponding author. Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, PR China.Background: Myasthenia gravis (MG) is an autoimmune disease characterized by generalized skeletal muscle contraction weakness due to autoantibodies targeting neural-muscular junctions. Here, we investigated the relationship between key cytokines and MG type, disease course, antibodies, and comorbidities. Method: Cytokine levels in serum samples collected from MG (n = 45) and healthy control (HC, n = 38) patients from January 2020 to June 2022 were quantified via flow cytometry. Results: Levels of IL-6 were higher in the MG group versus healthy individuals (p = 0.026) and in patients with generalized versus ocular MG (p = 0.019). IL-6 levels were positively correlated with QMG score. In patients with MG with both AChR and Titin antibodies, serum levels of sFas and granulysin were higher than in those with AChR alone (p = 0.036, and p = 0.028, respectively). LOMG had a reduction in serum levels of IL-2 compared to EOMG (p = 0.036). LOMG patients with diabetes had lower serum levels of IL-2, IL-4, and IFN-γ (p = 0.044, p = 0.038, and p = 0.047, respectively) versus those without diabetes. sFas in the MG with Abnormal thymus were reduced compared to those in MG with Normal thymus (p = 0.008). Conclusions: This study revealed a positive correlation between IL-6 level and MG status. Serum cytokine levels of the AChR + Titin MG group differed from those of the AChR group. LOMG had a lower IL-2 level. Comorbidities affect some cytokines in peripheral blood in MG serum.http://www.sciencedirect.com/science/article/pii/S2405844023109534Myasthenia gravisCytokineTitin
spellingShingle Shu-Li Wei
Chun-Lin Yang
Wei-Yue Si
Jing Dong
Xue-Lu Zhao
Peng Zhang
Heng Li
Cong-Cong Wang
Min Zhang
Xiao-Li Li
Rui-Sheng Duan
Altered serum levels of cytokines in patients with myasthenia gravis
Heliyon
Myasthenia gravis
Cytokine
Titin
title Altered serum levels of cytokines in patients with myasthenia gravis
title_full Altered serum levels of cytokines in patients with myasthenia gravis
title_fullStr Altered serum levels of cytokines in patients with myasthenia gravis
title_full_unstemmed Altered serum levels of cytokines in patients with myasthenia gravis
title_short Altered serum levels of cytokines in patients with myasthenia gravis
title_sort altered serum levels of cytokines in patients with myasthenia gravis
topic Myasthenia gravis
Cytokine
Titin
url http://www.sciencedirect.com/science/article/pii/S2405844023109534
work_keys_str_mv AT shuliwei alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT chunlinyang alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT weiyuesi alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT jingdong alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT xueluzhao alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT pengzhang alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT hengli alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT congcongwang alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT minzhang alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT xiaolili alteredserumlevelsofcytokinesinpatientswithmyastheniagravis
AT ruishengduan alteredserumlevelsofcytokinesinpatientswithmyastheniagravis